D’ADAMO
NAP PROFESSIONAL SERVICES
Deflect® (ABO Specific Lectin Blocker Formula)
120 VeggieCaps per bottle.
Suggested retail price: $34.95
Typically, lectins can bind to many of the carbohydrate antigens
found in the gut and immune system, causing a variety of health
problems. This is usually accomplished by direct agglutination of
the target cells. Lectins can occur in very common foods in the
diet, and the majority is specific for the carbohydrates of the ABO
blood typing system.
Clinical Indications
• Intestinal dysbiosis
• Bowel hyperpermiability
• Immune dysfunction
• Food sensitivities and systemic inflammation
• Metabolic Syndrome
• Carbohydrate intolerant individuals who typically gain
weight on high carbohydrate diets.
In one study, the edible parts of 29 of 88 foods tested, including
common salad ingredients, fresh fruits, roasted nuts, and processed
cereals were found to possess significant lectin-like activity as
assessed by hemagglutination and bacterial agglutination assays.
Several common lectins, in particular, wheat germ agglutinin, are
known to bind to the insulin receptor and mimick the hormonal
effects of insulin on adipose tissue, an under-appreciated action
which can account for why individuals on high carbohydrate diets
often have difficulty contolling their weight. Thus, lectin blocking
is a safe and rational method for enhancing weight loss.
In the words of one lectin researcher:
“Most lectins in our diet are resistant to breakdown during gut passage and
are bound and endocytosed by epithelial cells. These lectins are powerful
exogenous growth factors for the small intestine, can induce dramatic
shifts in its bacterial flora and interfere with its hormone secretion. In
addition, lectins that are transported across the gut wall into the systemic
circulation can modulate the body’s hormone balance, metabolism and
health. Although these physiological effects are mediated or reinforced by
immune responses, they are primarily the result of the specific chemical
reactivity of lectins with cell surface receptors of the gut.”
Actions and Indications
The Deflect® formula provides a source of free blocking amino
sugars which bind and block lectins before they can attach to
the cells.
Since each blood type is succeptible to lectins with different
carbohydrate specificities, Dr. D’Adamo designed formulas to
block lectins by using mono and polysaccharides specific for
each blood type.
The amino sugars in Deflect® encourage healthy bowel flora,
although they do not provide a source of flora themselves.
These same amino sugars are healthy enhancers of joint gliding
surface and synovia as well.
One way this repair mechanism works is by ‘prying off’
lectins which have already adhered to cellular receptors, such
as insulin. Since insulin blockage by dietary lectins has been
linked to both insulin resistance and obesity, using Deflect® can
help accelerate weight reduction in diet-compliant individuals
by speeding up the time it takes for the regeneration of new
insulin receptors or the ‘cleansing’ of the old ones.
This can take upwards of one year in some individuals who
just follow the diet, and explains why some dieters do not see
weight loss in the early stages of the program. It is because of
this ‘lectin-locking’ function that many other diets (which do
have accelerated weight loss in their early stages) cause their
followers to lose muscle mass and fat -when what we want is
to lose only the fat. If the weight loss in the Blood Type Diet
is occasionally slow, at least it is healthy: Losing only body fat
means that a person’s weight loss can sometimes be only 50%
as rapid as other programs which are destroying muscle and fat.
The problem is that muscle is hard to get back, and any drop
in muscle mass results in a lower metabolic rate, leaving the
dieter more likely to gain back the weight, but this time only
in body fat.
Many lectins can amplify the effects of auto-immune disease,
such as thyroiditis, rheumatoid arthritis, schleroderma,
fibromylagia and pemphigus. Research shows that some of the
lectins that can cause this may actually be manufactured by the
body itself (serum lectins). By acting as sacrificial molecules,
Deflect® can block this action.
Many people with ‘food sensitivities’ or ‘leaky gut’ have a
phenomena called ‘active endocytosis’ where prior lectin
damage results in an intestinal absorption surface that actively
scoops up macromolecules. Because these larger molecules are
very antigenic, they tend to increase local inflammation and
thus increase the leaky gut. Again, by acting like ‘sacrifical
molecules’ Deflect® can block this, while also inhibiting bacterial
adhesion to the gut as well (bacteria use their own lectins to attach
to the intestines) a secondary cause of leaky gut. The amino sugars
in Deflect® can also help prevent re-infection by H. pylori and
many gram-negative bacteria which cause bladder infections, by
flooding their own lectin receptors, thereby preventing adhesion,
the first step needed for infection.
The amino sugars in Deflect encourage healthy bowel flora,
®
although they do not provide a source of flora themselves. These
same amino sugars are healthy enhancers of joint gliding surface
and synovia as well.
Synergistic Products
• Redoxa, Quercetin (Leaky gut support in all types)
• Itaru’s Tea (Weight management in all types)
• Polyflora O, Polyflora A, Polyflora B, Polyflora AB (Dysbiosis
in all types)
• Bromelain (Joint dysfunction in all types)
Dosage
• Weight management and anti-lectin support: 1-2 capsules
with meals
• Other conditions: 1-2 capsule twice daily away from meals
See Also
• Boyd’s Report of Lectin Specificity
• Dietary lectins are metabolic signals for the gut and modulate
immune and hormone functions
• Dietary lectins can induce in vitro release of IL-4 and IL-13
from human basophils
• Glycosylation
• Lectins, Mitogen and Blastogenic Effects
• Lectins, Resistance to Degradation
• Lectins in the United States Diet
• Microvilli
• Mitogen
• Mitosis
• Mucosa
References
1. Basso, D. (1995). Living calcareous algae by a paleontological approach:
1. Freed DJ. British Medical Journal, 1999 Apr 17;318(7190):1023-4.
2. Pusztai A. Dietary lectins are metabolic signals for the gut and modulate
immune and hormone functions. Eur J Clin Nutr 1993 Oct;47(10):691-9
3. Irache JM, Durrer C, Duchene D, Ponchel Bioadhesion of lectin-latex
conjugates to rat intestinal mucosa. Pharm Res 1996 Nov;13(11):1716-9
4. Acarin L, Vela JM, Gonzalez B, Castellano B Demonstration of poly-
N-acetyl lactosamine residues in ameboid and ramified microglial cells
in rat brain by tomato lectin binding. J Histochem Cytochem 1994
Aug;42(8):1033-41
5. Hussain N, Jani PU, Florence AT Enhanced oral uptake of tomato
lectinconjugated nanoparticles in the rat. Pharm Res 1997 May;14(5):613-
8
6. Chuang JS, Callaghan JM, Gleeson PA, Toh BH Diagnostic ELISA for
parietal cell autoantibody using tomato lectin-purified gastric H+/K(+)-
ATPase (proton pump). Autoimmunity 1992;12(1):1-7
7. Tariq SM, Stevens M, Matthews S, Ridout S, Twiselton R, Hide DW
Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ
1996 Aug 31;313(7056):514-7
8. Gan RL[Peanut lectin-binding sites in gastric carcinoma and the adjacent
mucosa]. Chung-hua Ping Li Hsueh Tsa Chih 1990 Jun;19(2):109-11
9. Lin M, et al Peanut lectin-binding sites and mucins in benign and
malignant colorectal tissues associated with schistomatosis. Histol
Histopathol. 1998 Oct;13(4):961-6.
10. Melato M, et al The lectin-binding sites for peanut agglutinin in
invasive breast ductal carcinomas and their metastasis. Pathol Res Pract.
1998;194(9):603-8.
11. Jordinson M, Playford RJ, Calam Effects of a panel of dietary lectins on
cholecystokinin release in rats. Am J Physiol 1997 Oct;273(4 Pt 1):G946-
50
12. Jordinson M, et al Soybean lectin stimulates pancreatic exocrine secretion
via CCK-A receptors in rats Am J Physiol. 1996 Apr;270(4 Pt 1):G653-9.
13. Mikkat U, Damm I, Schroder G, Schmidt K, Wirth C, Weber H, Jonas L
Effect of the lectins wheat germ agglutinin (WGA) and Ulex europaeus
agglutinin
14. (UEA-I) on the alpha-amylase secretion of rat pancreas in vitro and in
vivo. Pancreas 1998 May;16(4):529-38
15. Burks AW, et al Identification of peanut agglutinin and soybean trypsin
inhibitor as minor legume allergens. Int Arch Allergy Immunol. 1994
Oct;105(2):143-9.
16. Buchanan and Higley : The relationship of blood groups to disease. Br. J.
Exp. Path. (1921) 2;227
17. Springer GF. Relation of blood group active plant substances to human
blood groups. Acta Haem. 20 (1958) 147-55
18. Alderman S, Kailas S, Goldfarb S, Cholestatic hepatitis after
ingestion of chaparral leaf: confirmation by endoscopic retrograde
cholangiopancreatography and liver biopsy. Clin Gastroenterol 1994
Oct;19(3):242-7
19. Okada Y, Jinno K, Moriwaki S, Shimoe T, Tsuji T, Murakami M, Thurin
J, Koprowski H Blood group antigens in the intrahepatic biliary tree. I.
Distribution in the normal liver. J Hepatol 1988 Feb;6(1):63-70
20. Jordinson M, Playford RJ, Cala Am J Physiol Effects of a panel of dietary
lectins on cholecystokinin release in rats 1997 Oct;273(4 Pt 1):G946-50
21. Pusztai A Dietary lectins are metabolic signals for the gut and modulate
immune and hormone functions. Eur J Clin Nutr. 1993 Oct;47(10):691-9.
Review
22. Ruhlmann J, Sinha P, Hansen G, Tauber R, Kottgen E Studies on the
aetiology of coeliac disease: no evidence for lectin-like componentsn
wheat gluten. Biochim Biophys Acta 1993 Jun 19;1181(3):249-56
23. Freed DJ Dietary Lectins in Food Allergy and Intolerance Brostoff and
Callacombe Editors Bailliere Tindall Publishers, London
24. Gendel, Steven M. (1998) Sequence Databases for Assessing the
Potential Allergenicity of Proteins Used in Transgenic Foods. Advances
in Food and Nutrition Research 42; 63-92.
25. Forssell F, Wieser H [Spelt wheat and celiac disease]. Z Lebensm Unters
Forsch 1995 Jul;201(1):35-9
26. Falth-Magnusson K, et al. Elevated levels of serum antibodies to the lectin
wheat germ agglutinin in celiac children lend support to the gluten-lectin
theory of celiac disease. Pediatr Allergy Immunol. 1995 May;6 (2):98-102.
27. Brady PG, Vannier AM, Banwell JG Identification of the dietary lectin,
wheat germ agglutinin, in human intestinal contents. Gastroenterology 1978
Aug;75(2):236-9
28. Pusztai A, Ewen SW, Grant G, Brown DS, Stewart JC, Peumans WJ, Van
Damme EJ, Bardocz S Antinutritive effects of wheat-germ agglutinin and
other N-acetylglucosamine-specific lectins. Br J Nutr 1993 Jul;70(1):313-21
29. Deschodt-Lanckman M, Robberecht P, Camus JC, Christophe J Wheat germ
agglutinin inhibits basal- and stimulated-adenylate cyclase activity as well as
the binding of [3H] caerulein to rat pancreatic plasma membranes J Cyclic
Nucleotide Res 1977 Jun;3(3):177-87
30. Ponzio G, Debant A, Contreres JO, Rossi B Wheat-germ agglutinin mimics
metabolic effects of insulin without increasing receptor autophosphorylation
Cell Signal 1990;2(4):377-86
31. Wu AM, Wu JH, Song SC, Tsai MS, Herp A. Studies on the binding of wheat
germ agglutinin (Triticum vulgaris) to O-glycans. FEBS Lett 1998 Dec
4;440(3):315-9
32. N, Taminato T, Ida T, Seno M, Seino Y, Matsukura S, Kuno S, Imura H
Detection of antibodies against wheat germ agglutinin bound glycoproteins
on the islet-cell membrane. Diabet Med 1988 Mar;5(2):139-44
33. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter
JI Increased intestinal permeability in patients with Crohn’s disease and their
relatives. A possible etiologic factor. Ann Intern Med 1986 Dec;105(6):883-5
34. Nachbar MS, Oppenheim JD Lectins in the United States diet: a survey of
lectins in commonly consumed foods and a review of the literature. (SV)
Am J Clin Nutr 1980 Nov;33(11):2338-45 Prog Food Nutr Sci 1989;13(3-
4):317-48
35. Erickson RH, Kim J, Sleisenger MH, Kim YS Effect of lectins on the activity
of brush border membrane-bound enzymes of rat small intestine. J Pediatr
Gastroenterol Nutr 1985 Dec;4(6):984-91
36. Weinman MD, Allan CH, Trier JS, Hagen SJ Repair of microvilli in the rat
small intestine after damage with lectins contained in the red kidney bean.
Gastroenterology 1989 Nov;97(5):1193-204
37. Greer F, Pusztai A Toxicity of kidney bean (Phaseolus vulgaris) in rats:
changes in intestinal permeability. Digestion 1985;32(1):42-6
38. Grant G Anti-nutritional effects of soyabean: a review. J Anim Sci 1982
Nov;55(5):1087-98
39. Aletor VA Effect of dietary sub-lethal doses of lima bean lectin on
relative organ weights, pancreatic and intestinal trypsin (EC 3.4.21.4) and
chymotrypsin (EC 3.4.21.1) in the rat. Nahrung 1989;33(4):355-60
40. Toro F, Benshimol AL, Gonzalez Elorriaga M, Soyano A Spleen and thymus
histology and proliferative response of splenic cells in rats fed raw and cooked
Phaseolus vulgaris beans. (SJ)Arch Latinoam Nutr 1992 Dec;42(4):395-402
41. Henney L, Ahmed EM, George DE, Kao KJ, Sitren HS Tolerance to long-
term feeding of isolated peanut lectin in the rat: evidence for a trophic effect
on the small intestines J Nutr Sci Vitaminol (Tokyo) 1990 Dec;36(6):599-607
42. Myer RO, Froseth JA, Coon CN Protein utilization and toxic effects of raw
beans (Phaseolus vulgaris) for young pigs. J Anim Sci. 1982 Nov;55(5):1087-
98.
43. Grant G, More LJ, McKenzie NH, Stewart JC, Pusztai A A survey of the
nutritional and haemagglutination properties of legume seeds generally
available in the UK. Br J Nutr 1983 Sep;50(2):207-14
44. Chiba M, et al Anti-erythrocyte antibodies in ulcerative colitis: case report
and discussion on the pathophysiology of anti-erythrocyte antibody.
Gastroenterol Jpn. 1988 Oct;23(5):564-9.
45. 4Vesely KT. Frequency of blood groups of the ABC and Rho(D) system in
patients with viral hepatitis,
46. Springer GF Importance of blood-group substances in interactions between
man and microbes. Ann NY Acad Sci. 1970 Feb 13;169(1):134-52.
47. Variyam EP, Hoskins LC Mucin degradation in human colon ecosystems.
Degradation of hog gastric mucin by fecal extracts and fecal cultures.
Gastroenterology 1981 Oct;81(4):751-8
48. Springer GF. Role of human cell surface structures in interactions between
man and microbes. Naturwissenschaften. 1970 Apr;57(4):162-71.
49. Yang N, Boettcher B Development of human ABO blood group A antigen
on Escherichia coli Y1089 and Y1090. Immunol Cell Biol 1992 Dec;70 (
Pt 6):411-6
50. Lindstedt R, Larson G, Falk P, Jodal U, Leffler H, Svanborg C The receptor
repertoire defines the host range for attaching Escherichia coli strains that
recognize globo-A. Infect Immun 1991 Mar;59(3):1086-92
51. Essery SD, et al Detection of microbial surface antigens that bind Lewis(a)
antigen. FEMS Immunol Med Microbiol. 1994 Jun;9(1):15-21.
52. Tosh FD, et al Characterization of a fucoside-binding adhesin of Candida
albicans. Infect Immun. 1992 nov;60(11):4734-9.
53. Osipova SO, et al [The ABO system and Lamblia infection. 2. The secretion
of ABO system antigens and level of the specific humoral response in
persons with Lamblia infection and the presence of group-specific antigens
in Lamblia].
54. Med Parazitol (Mosk). 1985 Nov-Dec;(6):16-9. Russian.
55. Jordinson M, et al Vicia faba agglutinin, the lectin present in broad beans,
stimulates differentiation of undifferentiated colon cancer cells. Gut. 1999
May;44(5):709-714.
56. Itzkowitz SH Blood group-related carbohydrate antigen expression in
malignant and premalignant colonic neoplasms. J Cell Biochem Suppl
1992;16G:97-101
57. Denk H, Holzner JH, Obiditsch-MayrEpithelial blood group antigens in
colon polyps. I. Morphologic distribution and relationship to differentiation.
J Natl Cancer Inst 1975 Jun;54(6):1313-7
58. Li R, et al [Subcellular localization of blood group substances ABH in human
gastrointestinal tracts]. Chung KuoHsueh Ko Hsueh Yuan Hsueh Pao. 1996
Feb;18(1):49-53. Chinese.
59. Itzkowitz SH, Dahiya R, Byrd JC, Kim YS Blood group antigen synthesis
and degradation in normal and cancerous colonic tissues. Gastroenterology
1990 Aug;99(2):431-42
60. Vowden P, Lowe AD, Lennox ES, Bleehen NM Thyroid blood group
isoantigen expression: a parallel with ABH isoantigen expression in the
distal colon. Br J Cancer 1986 Jun;53(6):721-5
61. Schumacher U, Higgs D, Loizidou M, Pickering R, Leathem A, TaylorCancer
1994 Dec 15;74(12):3104-3107 Helix pomatia agglutinin binding is a useful
prognostic indicator in colorectal carcinoma.
62. Campbell BJ, et al Direct demonstration of increased expression of
Thomsen-Friedenreich (TF antigen in colonic adenocarcinoma and
ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest.
1995 Feb;95(2):571-6.
63. Datta PK, et al Enhancement of lectin-erythrocyte agglutination by gums.
Biochim Biophys Acta. 1988 Nov 2;957(1):164-7.
64. Melito C, et al Vegetable gums modify lectin hemagglutinability. Acta Cient
Venez. 1992;43(5):312-4.
65. Clausen H, et al . Monoclonal antibodies directed to the blood group A
associated structure, galactosyl-A: specificity and relation to the Thomsen-
Friedenreich antigen. Mol Immunol. 1988 Feb;25(2):199-204.
66. Wu AM, et al Binding studies on the combining site of a GalNAc alpha
1-->-specific lectin with Thomsen-Friedenreich activity prepared from green
marine algae Codium fragile subspecies tomentosoides.
67. Murayama T, et al. Colon carcinoma glycoproteins carrying alpha 2,6-linked
sialic acid reactive with Sambucus nigra agglutinin are not constitutively
expressed in normal human colon mucosa and are distinct from sialyl-Tn
antigen. Int J Cancer. 1997 Mar 4;70(5):575-81.
68. Boland CR, et al Use of the lectin from Amaranthus caudatus as a
histochemical probe of proliferating colonic epithelial cells Cancer Res.
1991 Jan 15;51(2):657-65.
69. Poola I, et al. Purification and saccharide-binding charcteristics of a rice
lectin. Carbohydr Re. 1986 Feb 1;146(2):205-217
70. Springer GF. Relation of blood group active plant substances to human blood
groups. Acta Haem. 20 (1958) 147-55
71. Freed DL, et al Letter: Do dietary lectins protect against colonic cancer?
Lancet. 1975 Dec 20;2(7947):1261-2.
72. Bardocz S, et al. Reversible effect of phytohaemagglutinin on the growth and
metabolism of rat gastrointestinal tract. Gut. 1995 Sep;37(3):353-60.
73. Pusztai, A. (1995) Proc. Int. Symp. Control. Rel. Bioact. Mater. 22, 161-162
74. Tchernychev B, et al Natural human antibodies to dietary lectins. FEBS Lett.
1996 Nov 18;397(2-3):139-42.
75. Seaweeds and Their Uses (Levring, Hoppe and Schmid, 1969) by V.J.
Chapman (Professor of Botany, Auckland University) 1970.
Model: BT004O Model: BT004AB
* Manufactured by: Blood Type Diet * Manufactured by: Blood Type Diet

Model: BT004A Model: BT004B

* Manufactured by: Blood Type Diet * Manufactured by: Blood Type Diet

copyright © 2010, North American Pharmacal, Inc. All Rights Reserved. REV:051810:wst
These statements have not been evaluated by the FDA (U.S. Food & Drug Administration).
Our products are not intended to diagnose, cure or prevent any disease. If a condition persists, please contact your physician.
North American Pharmacal, Inc.  •  213 Danbury Road, Wilton, CT 06897  Toll Free USA (877) 226-8973 or (203) 761-0042  •  www.4yourtype.com